Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver

Concanavalin A (ConA), directly injected into mice, induces T cell–mediated liver injury. However, it remains unclear whether ConA injection can activate innate immune cells, including natural killer (NK) cells and natural killer T (NKT) cells, both of which exist abundantly in the liver. Here we report that ConA injection stimulated interferon (IFN)‐γ production from liver NKT cells as early as 2 hours after injection and augmented YAC‐1 cytotoxicity of liver NK cells. ConA‐induced NK cell activation required other types of immune cells and critically depended on IFN‐γ. Because a nonhepatotoxic low dose of ConA was capable of fully activating both NKT cells and NK cells, we next addressed the possibility of ConA injection displaying an antitumor effect in the liver without liver injury. A nonhepatotoxic low‐dose ConA injection augmented the cytotoxicity of liver NK cells against Colon‐26 colon cancer cells and suppressed hepatic metastasis of Colon‐26 cells in a NK cell– and IFN‐γ–dependent manner. In conclusion, a nonhepatotoxic low dose of ConA might serve as an immunomodulator that can preferentially activate the innate immune cells to induce an antitumor effect against metastatic liver tumor. (HEPATOLOGY 2004;40:1190–1196.)

[1]  H. Wakao,et al.  The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response , 2003 .

[2]  N. Hayashi,et al.  CD1d‐mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver , 2003, International journal of cancer.

[3]  W. Paul,et al.  Nonredundant Roles for CD1d-restricted Natural Killer T Cells and Conventional CD4+ T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of Mice , 2003, The Journal of experimental medicine.

[4]  H. Wakao,et al.  The regulatory role of Valpha14 NKT cells in innate and acquired immune response. , 2003, Annual review of immunology.

[5]  Kazuyoshi Takeda,et al.  New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.

[6]  G. Tiegs,et al.  Cytokine expression in three mouse models of experimental hepatitis. , 2002, Cytokine.

[7]  D. Pellicci,et al.  Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. , 2002, Blood.

[8]  T. Waldmann,et al.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. , 2001, Immunity.

[9]  T. Papadopoulos,et al.  Importance of Kupffer cells for T-cell-dependent liver injury in mice. , 2000, The American journal of pathology.

[10]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[11]  L. Kaer,et al.  Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide , 2000, European journal of immunology.

[12]  L. Kaer,et al.  The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. , 2000, International immunology.

[13]  L. Kaer,et al.  Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Macdonald,et al.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells , 2000, European journal of immunology.

[15]  R. Wiltrout.  Regulation and antimetastatic functions of liver‐associated natural killer cells , 2000, Immunological reviews.

[16]  G. Fantuzzi,et al.  Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[18]  G. Del Sero,et al.  NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. , 2000, Gastroenterology.

[19]  M. Taniguchi,et al.  Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis , 2000, The Journal of experimental medicine.

[20]  H. Moriwaki,et al.  IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. , 1999, International immunology.

[21]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[22]  T. Mak,et al.  Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. , 1997, Journal of immunology.

[23]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[24]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[25]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[26]  S. Toyabe,et al.  Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. , 1997, Journal of immunology.

[27]  M. Atkins,et al.  Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  M. Taniguchi,et al.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.

[29]  S. Küsters,et al.  Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.

[30]  H. Fujiwara,et al.  Critical involvement of interferon γ in the pathogenesis of T‐cell activation‐associated hepatitis and regulatory mechanisms of interleukin‐6 for the manifestations of hepatitis , 1996, Hepatology.

[31]  M. Miyazaki,et al.  Mechanisms of interleukin-2-induced hepatic toxicity. , 1996, Cancer research.

[32]  K. Takeda,et al.  Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. , 1995, Journal of immunology.

[33]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[34]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[35]  M. Capra,et al.  CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. , 1991, Journal of immunology.

[36]  S. Rosenberg,et al.  Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. , 1985, Cancer research.

[37]  T. Tsuruo,et al.  Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. , 1983, Cancer research.